Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (171)

71

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

enthalten in: AIDS (London, England) | 2009

von Bénard, A. | Damond, F. | Campa, P. | +10

72

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

enthalten in: AIDS (London, England) | 2009

von Haubrich, R. | Riddler, S. | DiRienzo, A. | +96

CommentIn: AIDS. 2009 Aug 24;23(13):1727-9. - PMID 19571724

73

Clinical experience with the combined use of lopinavir/ritonavir and rifampicin

enthalten in: AIDS (London, England) | 2009

von L'homme, R. | Nijland, H. | Gras, L. | +7

74

Protease inhibitor levels in hair strongly predict virologic response to treatment

enthalten in: AIDS (London, England) | 2009

von Gandhi, M. | Ameli, N. | Bacchetti, P. | +9

75

HIV monotherapy with ritonavir-boosted protease inhibitors : a systematic review

enthalten in: AIDS (London, England) | 2009

von Bierman, W. | van Agtmael, M. | Nijhuis, M. | +2

CommentOn: AIDS. 2004 Apr 9;18(6):955-7. - PMID 15060447

76

Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults

enthalten in: AIDS (London, England) | 2008

von Carr, A. | Ritzhaupt, A. | Zhang, W. | +5

77

Switching to darunavir/ritonavir achieves viral suppression in patients with persistent low replication on first-line lopinavir/ritonavir

enthalten in: AIDS (London, England) | 2008

von Chaix, M. | Sahali, S. | Pallier, C. | +3

78

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

enthalten in: AIDS (London, England) | 2008

von Gupta, S. | Rosenkranz, S. | Cramer, Y. | +4

79

Noninferiority and lopinavir/ritonavir monotherapy trials

enthalten in: AIDS (London, England) | 2008

von Pulido, F. | Arribas, J.

CommentOn: AIDS. 2008 May 11;22(8):996-7. - PMID 18453863

80

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

enthalten in: AIDS (London, England) | 2008

von Ortiz, R. | Dejesus, E. | Khanlou, H. | +9